E-Mail
DURHAM, N.C. - A newly identified group of antibodies that binds to a coating of sugars on the outer shell of HIV is effective in neutralizing the virus and points to a novel vaccine approach that could also potentially be used against SARS-CoV-2 and fungal pathogens, researchers at the Duke Human Vaccine Institute report.
In a study appearing online May 20 in the journal
Cell, the researchers describe an immune cell found in both monkeys and humans that produces a unique type of anti-glycan antibody. This newly described antibody has the ability to attach to the outer layer of HIV at a patch of glycans the chain-like structures of sugars that are on the surfaces of cells, including the outer shells of viruses.
Alberto-bartesaghi
Richard-laga
Kartik-manne
Matthews-lee
Sophie-gobeil
S-munir-alam
Josephr-francica
Wilton-williams
Megan-kopp
R-ryan-meyerhoff
Garnett-kelsoe
Marioj-borgnia